n,n-dimethylarginine has been researched along with Lupus Erythematosus, Systemic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, IK; Ali, SR; Elmageed, AM; Saleh, BI | 1 |
| Bultink, IE; Dijkmans, BA; Heijst, JA; Teerlink, T; Voskuyl, AE | 1 |
| Kiani, AN; Mahoney, JA; Petri, M | 1 |
3 other study(ies) available for n,n-dimethylarginine and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Exploring disease activity and cardiovascular events by raised serum asymmetric dimethyl arginine among systemic lupus erythematosus patients.
Topics: Adult; Arginine; Cardiovascular Diseases; Cholesterol; Complement C3; Cross-Sectional Studies; Egypt; Female; Humans; Logistic Models; Lupus Erythematosus, Systemic; Male; Surveys and Questionnaires | 2011 |
Raised plasma levels of asymmetric dimethylarginine are associated with cardiovascular events, disease activity, and organ damage in patients with systemic lupus erythematosus.
Topics: Adult; Arginine; Biomarkers; Cardiovascular Diseases; Female; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Nitric Oxide Synthase; Regression Analysis; Risk Factors; Severity of Illness Index | 2005 |
Asymmetric dimethylarginine is a marker of poor prognosis and coronary calcium in systemic lupus erythematosus.
Topics: Adult; Antibodies, Antinuclear; Arginine; Biomarkers; Calcinosis; Coronary Angiography; Coronary Disease; Ethnicity; Female; Humans; Lipids; Lupus Erythematosus, Systemic; Male; Maryland; Prognosis; Risk Factors | 2007 |